Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced financial results for the three and nine months ended September 30, 2016. Third Quarter 2016 Financial and …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Graham G. Miao, Ph.
Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) are down after the specialty pharma company initiated a reverse split of its common stock at a …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the distribution of TREXIMET® (sumatriptan and naproxen sodium) 10/60 mg to wholesalers has begun. TREXIMET 10/60 mg …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that Marsha Stanton, Ph.D.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that the United States Patent and Trademark Office has issued U.S.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced that the Company presented a …
In a research report issued Friday, Brean Capital analyst Difei Yang downgraded shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) from Buy to Hold, after the pharma …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2016. …
In a research report published Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), with …
